Form D · Other Health Care
HealthBridge Financial, Inc.
Grand Rapids, MI · CIK 0001712468
Offering snapshot reported Dec 22, 2025 · SEC filing
- Reported sold
- $17.9M Offering amount: $18.6M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 26, 2024 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$3,300,000 → $17,899,968
- Reported investors4 → 15
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 22, 2025 | Amendment | $17,899,968 | $14,599,968vs Oct 15, 2024 | 15 | SEC filing |
| Dec 22, 2025 | Initial | $20,000,000 | No comparison | 7 | SEC filing |
| Oct 15, 2024 | Initial | $3,300,000 | No comparison | 4 | SEC filing |
| May 9, 2024 | Initial | $6,618,149 | No comparison | 34 | SEC filing |
| Apr 25, 2023 | Initial | $8,365,053 | No comparison | 2 | SEC filing |
| Jun 21, 2022 | Initial | $2,780,392 | No comparison | 8 | SEC filing |
| May 17, 2021 | Initial | $14,164,594 | No comparison | Not reported | SEC filing |
| Apr 15, 2020 | Initial | $1,500,000 | No comparison | 4 | SEC filing |
| May 8, 2019 | Initial | $8,291,149 | No comparison | 23 | SEC filing |
| Jul 9, 2018 | Initial | $629,000 | No comparison | 11 | SEC filing |
| Jul 24, 2017 | Initial | $900,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $825K
- Form D file number
- 021-526677
Offer and Sale of Convertible Promissory Notes (and the shares issuable thereunder)
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Navidar Group LLC | 148011 | Navidar Group LLC · CRD 148011 |
Source: Form D, filed Dec 22, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph B. Anderson | Director |
| Amy O'meara Chambers | Executive |
| Amy Chambers | Director, Executive |
| Mark Chess | Director |
| Mike De Vries | Director |
| Gian Fulgoni | Director |
| Timothy Heger | Executive |
| Paul Iles | Executive |
| Matt Kinley | Director |
| Daniel Malven | Director |
| Dan Malven | Director |
| Tami Reller | Director |
| Greg Robinson | Director, Promoter |
| James Slubowski | Executive |
| Hin King Tai | Director |
| Gregory Vanden Bosch | Director, Executive |
| Ryan Wheeler | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:Grand Rapids, MI, 49512